Page 54 - Multiple Sclerosis News Today

Clene Inc. (NASDAQ:CLNN – Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 222,300 shares, a decline of 22.6% from the January 15th total of 287,200 shares. Based on an average trading volume of 900,200 shares, the short-interest ratio is […]

Biogen on Tuesday reported fourth-quarter results that fell short of Wall Street expectations as uptake of its newer drugs failed to offset declining...

A reward is still being offered for the arrest of individual responsible for Blackburn's death.

Fifteen years have passed since Danielle Blackburn was tragically found unconscious in a Fort Myers apartment, and authorities still need the public's help.

A longitudinal, observational study found that the choroid plexus, a network of blood vessels in each ventricle of the brain, plays a potential role in the neurodegenerative and chronic inflammatory process experienced by patients with relapsing remitting multiple sclerosis (MS).

Cell therapies were first validated in cancer, but Kyverna Therapeutics aims to show they’re safe enough for autoimmune diseases. The biotech plans to deploy its IPO cash across clinical trials in lupus nephritis, multiple sclerosis, systemic sclerosis, and myasthenia gravis.

A Free Online Event That Unveils Cutting-Edge Approaches Reversing Multiple Sclerosis and Other Neuroimmune Conditions Key Takeaways: The Multiple Sclerosis...

BioNxt Reports Successful Results From ODF Cladribine Toxicity Study

 

Peter Crouch has ribbed wife Abbey Clancy after she laid the law at home with a new quirky rule.